Vyome Holdings, Inc (HIND): Nasdaq/NYSE listing notice — ReShape Lifesciences receives Nasdaq non-compliance notice for bid price below $1.00

Vyome Holdings, Inc

Received Bid Price Notice on October 10, 2023 for failing to meet minimum $1.00 bid price per share.
Company has 180 calendar days to regain compliance by closing at $1.00 for 10 consecutive days.
If not compliant, may seek additional 180 days and consider reverse stock split to cure deficiency.
Stock trades on Nasdaq Capital Market (ticker RSLS); non-compliance threatens continued listing.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Vyome Holdings, Inc received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

October 10, 2023, ReShape Lifesciences Inc. (the “Company”) received a written notice (the “Bid Price Notice”) from the Listing Qualifications department (the “Nasdaq Staff”) of The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is not in compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. The Nasdaq Listing Rules require listed securities to maintain a minimum bid price of $1.00 per share and, based upon the closing bid price for the last 30 consecutive business days, the Company no

View on SEC.gov

Browse all listing & compliance notices →

Vyome Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001104659-23-109130

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.